España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Biomind Labs
BMNDF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.7000
At close: Jan 30, 4:00 PM EDT
$0.2221
-0.48
-68.27%
After Hours: Jan 30, 4:00 PM EDT
Get Report
Comment
Biomind Labs (BMNDF) Forecast
News
Earnings
Biomind Labs (BMNDF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Biomind Labs (OTC:BMNDF) Stock
Biomind Labs Stock (OTC: BMNDF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, January 27, 2023
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, January 26, 2023
Psychedelic Stock Gainers And Losers From January 26, 2023
Benzinga Insights
Wednesday, January 25, 2023
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, January 24, 2023
Psychedelic Stock Gainers And Losers From January 24, 2023
Benzinga Insights
Friday, December 30, 2022
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
Lara Goldstein
Tuesday, November 22, 2022
Psychedelic Stock Gainers And Losers From November 22, 2022
Benzinga Insights
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Lara Goldstein
Monday, November 21, 2022
Psychedelic Stock Gainers And Losers From November 21, 2022
Benzinga Insights
Friday, November 18, 2022
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, November 17, 2022
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, November 16, 2022
Psychedelic Stock Gainers And Losers From November 16, 2022
Benzinga Insights
Tuesday, November 15, 2022
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
Lara Goldstein
Thursday, November 10, 2022
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, November 09, 2022
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, November 08, 2022
Psychedelic Stock Gainers And Losers From November 8, 2022
Benzinga Insights
Monday, November 07, 2022
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, November 04, 2022
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
Lara Goldstein
Thursday, November 03, 2022
Psychedelic Stock Gainers And Losers From November 3, 2022
Benzinga Insights
Wednesday, November 02, 2022
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, October 27, 2022
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, October 26, 2022
Psychedelic Stock Gainers And Losers From October 26, 2022
Benzinga Insights
Tuesday, October 25, 2022
Psychedelic Stock Gainers And Losers From October 25, 2022
Benzinga Insights
Friday, October 21, 2022
Allied, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, October 18, 2022
Psychedelic Stock Gainers And Losers From October 18, 2022
Benzinga Insights
Monday, October 17, 2022
Psychedelic Stock Gainers And Losers From October 17, 2022
Benzinga Insights
Friday, October 14, 2022
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, October 12, 2022
Psychedelic Stock Gainers And Losers From October 12, 2022
Benzinga Insights
Tuesday, October 11, 2022
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, October 10, 2022
Psychedelic Stock Gainers And Losers From October 10, 2022
Benzinga Insights
Thursday, October 06, 2022
Psychedelic Stock Gainers And Losers From October 6, 2022
Benzinga Insights
Tuesday, October 04, 2022
Allied, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, October 03, 2022
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, September 30, 2022
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Psyched: Autopsy Reveals Death By Ketamine, LSD-Like Drugs Without Hallucinations, DEA & Right To Try Psilocybin
Lara Goldstein
Thursday, September 29, 2022
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, September 28, 2022
Psychedelic Stock Gainers And Losers From September 28, 2022
Benzinga Insights
Tuesday, September 27, 2022
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Canadian Psychedelics Firm And Queens College Develop New Transdermal Drug Delivery System
Lara Goldstein
Monday, September 26, 2022
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, September 23, 2022
Clinical Study On DMT Inhaled Product For Treatment-Resistant Depression Completes Dosing Stage
Lara Goldstein
Thursday, September 22, 2022
Psychedelic Stock Gainers And Losers From September 22, 2022
Benzinga Insights
Wednesday, September 21, 2022
Psychedelic Stock Gainers And Losers From September 21, 2022
Benzinga Insights
Tuesday, September 20, 2022
Seelos Therapeutics, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, September 19, 2022
Psychedelic Stock Gainers And Losers From September 19, 2022
Benzinga Insights
Thursday, September 15, 2022
Numinus Wellness, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, September 14, 2022
GH Research, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, September 12, 2022
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, September 09, 2022
Psychedelic Stock Gainers And Losers From September 9, 2022
Benzinga Insights
Thursday, September 08, 2022
Small Pharma, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Show More
